Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc > Share consolidations are amateurish at best

<< Previous

Bullboard Posts

Next >>

Post by XRRH2008on Jun 23, 2017 12:47pm

463 Views

Post# 26398430

Share consolidations are amateurish at best

Other than when timed with a strategic event / major milestone, share consolidations are what penny stocks in the junior mining and exploration space do when they have spent all their money without finding any valuable mineral deposits. Its desperate and amateurish.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China